Vera Therapeutics, Inc. (VERA)
43.71
-1.33
(-2.95%)
USD |
NASDAQ |
Apr 13, 16:00
43.68
-0.03
(-0.07%)
After-Hours: 20:00
Vera Therapeutics Cash from Investing (TTM) : 194.29M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Cogent Biosciences, Inc. | -399.53M |
| Syndax Pharmaceuticals, Inc. | 290.04M |
| United Therapeutics Corp. | -551.30M |
| Cytokinetics, Inc. | 16.67M |
| Insmed, Inc. | -64.58M |